Showing results (111-120 of 150) with videos related to
Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agentsTuan P Tran, Edmund L Ellsworth, Michael A Stier, et al.Antimicrobial Agents and Chemotherapy|May 4, 2016
Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular PathogensKarla D Passalacqua, Marie-Eve Charbonneau, Nicholas J Donato, et al.Journal of Medicinal Chemistry|May 5, 2018
Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate DehydrogenaseJoseph T Madak, Christine R Cuthbertson, Yoshinari Miyata, et al.Journal of Medicinal Chemistry|February 16, 1996
Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A J Bridges, et al.Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.Journal of Medicinal Chemistry|January 1, 1987
Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemiasH D Showalter, J L Johnson, J M Hoftiezer, et al.Digestive Diseases and Sciences|March 15, 2011
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitisManabu Okawada, Hiroyuki Koga, Scott D Larsen, et al.Nature Chemical Biology|January 31, 2012
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaJolanta Grembecka, Shihan He, Aibin Shi, et al.Journal of Medicinal Chemistry|August 24, 2000
Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src)A M Thompson, G W Rewcastle, S L Boushelle, et al.Bioorganic & Medicinal Chemistry|April 25, 2020
Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edemaXuwen Liu, Michael W Wilson, Kun Liu, et al.Pageof 15